We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.37B
AUM Growth
+$229M
Cap. Flow
-$532M
Cap. Flow %
-15.77%
Top 10 Hldgs %
13.55%
Holding
415
New
23
Increased
124
Reduced
57
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 15.05%
2 Healthcare 14.3%
3 Financials 10.86%
4 Industrials 10.41%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKE icon
76
Buckle
BKE
$2.37B
$15.6M 0.46%
767,283
+32,780
+4% +$593K
FULT icon
77
Fulton Financial
FULT
$4.64B
$15.5M 0.46%
1,660,237
+70,781
+4% +$696K
ONTO icon
78
Onto Innovation
ONTO
$15.3B
$14.8M 0.44%
496,998
+25,897
+5% +$859K
HMN icon
79
Horace Mann Educators
HMN
$2.11B
$14.4M 0.43%
432,461
+18,055
+4% +$672K
DECK icon
80
Deckers Outdoor
DECK
$13.3B
$14.4M 0.43%
393,480
+15,570
+4% +$538K
FISV
81
Fiserv Inc
FISV
$27.9B
$14.4M 0.43%
140,007
+1,271
+0.9% +$127K
CFR icon
82
Cullen/Frost Bankers
CFR
$10.2B
$14.3M 0.42%
223,976
+7,446
+3% +$522K
MSA icon
83
Mine Safety
MSA
$7.49B
$13.9M 0.41%
103,820
+3,863
+4% +$473K
JNJ icon
84
Johnson & Johnson
JNJ
$625B
$13.6M 0.4%
91,458
+6,021
+7% +$891K
SMP icon
85
Standard Motor Products
SMP
$911M
$13.6M 0.4%
304,645
+14,863
+5% +$656K
PBH icon
86
Prestige Consumer Healthcare
PBH
$2.6B
$13.6M 0.4%
373,462
-59,571
-14% -$2.22M
INDB icon
87
Independent Bank
INDB
$3.97B
$13.4M 0.4%
256,383
+56,304
+28% +$3.5M
AME icon
88
Ametek
AME
$58.2B
$13.2M 0.39%
133,162
+5,714
+4% +$552K
GOOG icon
89
Alphabet (Google) Class C
GOOG
$4.32T
$13M 0.38%
176,600
+5,860
+3% +$447K
ROP icon
90
Roper Technologies
ROP
$39.8B
$12.7M 0.38%
32,192
-3,307
-9% -$1.38M
MD icon
91
Pediatrix Medical
MD
$2.2B
$12.6M 0.37%
773,518
+29,722
+4% +$553K
RLJ icon
92
RLJ Lodging Trust
RLJ
$1.69B
$12.5M 0.37%
1,443,062
+52,672
+4% +$473K
WWD icon
93
Woodward
WWD
$21.4B
$12.3M 0.37%
153,913
+5,609
+4% +$451K
HRTX icon
94
Heron Therapeutics
HRTX
$92.9M
$12.2M 0.36%
820,539
+145,174
+21% +$2.27M
DHR.PRA
95
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
$12.2M 0.36%
8,222
-328
-4% -$461K
LVGO
96
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$11.9M 0.35%
85,253
+2,859
+3% +$348K
FNV icon
97
Franco-Nevada
FNV
$46B
$11.9M 0.35%
84,962
-2,324
-3% -$345K
UIS icon
98
Unisys
UIS
$217M
$11.9M 0.35%
1,111,280
+41,444
+4% +$476K
HD icon
99
Home Depot
HD
$355B
$10.9M 0.32%
39,366
+370
+0.9% +$100K
LRN icon
100
Stride
LRN
$3.43B
$10.8M 0.32%
410,080
-373,167
-48% -$14.4M

Similar funds

Palisade Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Palisade Capital Management held 415 positions worth $3.37B, up 7.3% from $3.14B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Palisade Capital Management withdrew a net $532M in Q3 2020, closing 23 positions and reducing 57 holdings. Its most notable exit was The Aaron's Company Inc Class A, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Palisade Capital Management opened a new position in Match Group worth $16.7M.

  • Palisade Capital Management's largest Q3 2020 buy was Match Group: 151,006 shares worth $16.7M.
  • Palisade Capital Management added most to National Instruments Corp in Q3 2020, an estimated $8.97M increase.
  • Palisade Capital Management's biggest Q3 2020 reduction was Zebra Technologies, cutting an estimated $33.2M.
  • Palisade Capital Management fully exited The Aaron's Company Inc Class A in Q3 2020, selling an estimated $20.3M.
  • Palisade Capital Management's ten largest holdings make up 14% of its $3.37B portfolio in Q3 2020.
  • Palisade Capital Management opened 23 new positions and closed 23 in Q3 2020.
  • Palisade Capital Management's portfolio value rose 7.3% quarter-over-quarter to $3.37B.

Based on Palisade Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.